文献速递消化道肿瘤与早癌肝病

氧化修饰的蛋白质二硫键异构酶相关3促进异常角化不良素假尿苷酸合酶1介导的肝细胞癌恶性进展与存活

Oxidatively Modified Protein-Disulfide Isomerase-Associated 3 Promotes Dyskerin Pseudouridine Synthase 1-Mediated Malignancy and Survival of Hepatocellular Carcinoma Cells.
PubMed 文献 · Hepatology · 2018-07-23

该研究探讨肝细胞癌(HCC)中DKC1上调的调控机制,发现PDIA3与DKC1调控DNA结合并抑制DKC1表达,而活性氧(ROS)诱导PDIA3氧化修饰(Met338位点)使其转位至胞质,从而刺激DKC1表达,促进HCC细胞恶性进展与存活;HCC组织中ROS、胞质PDIA3与核DKC1水平呈正相关,PDIA3蛋白和DKC1 mRNA高表达患者无复发生存率降低。

要点

  • PDIA3通过识别DKC1基因座G-四链体DNA抑制DKC1表达。
  • ROS诱导PDIA3 Met338位点氧化修饰,使其转位至胞质并刺激DKC1表达。
  • HCC组织中ROS、胞质PDIA3与核DKC1水平呈正相关,高表达者无复发生存率降低。

核心结论

  • HCC中升高的ROS水平调节胞质PDIA3水平,通过上调DKC1促进HCC细胞存活。

研究设计与样本

  • 基础研究,采用液相色谱-串联质谱分析、CRISPR/Cas9敲入系统、异位表达系统和异种移植小鼠模型,并分析HCC组织与患者预后。

主要发现

  • PDIA3在HCC细胞中与DKC1调控DNA结合,但在ROS水平升高的HCC细胞中不结合。
  • PDIA3通过识别DKC1基因座G-四链体DNA抑制DKC1表达。
  • ROS诱导的PDIA3氧化修饰使其 redistributed 至胞质区域,刺激DKC1表达。
  • PDIA3的Met338被鉴定为氧化修饰残基。
  • 氧化修饰的PDIA3在体外和体内促进DKC1介导的HCC细胞恶性进展与存活。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Dyskerin pseudouridine synthase 1 (DKC1) is a conserved gene encoding the RNA-binding protein dyskerin, which is an essential component of the telomerase holoenzyme. DKC1 up-regulation is frequently observed in many different human cancers including hepatocellular carcinoma (HCC); however, its regulatory mechanisms remain unclear. Thus, we investigated the regulatory mechanism of DKC1 in HCC progression. We found that protein-disulfide isomerase-associated 3 (PDIA3) interacted with the DKC1 regulatory DNA in HCC cells but not in HCC cells with elevated reactive oxygen species (ROS) levels, using liquid chromatographic-tandem mass spectrometric analysis after isolating the DKC1 regulatory region binding proteins. PDIA3 repressed DKC1 expression in HCC cells by recognizing the G-quadruplex DNA at the DKC1 location. However, oxidative modification of PDIA3 induced by ROS redistributed this protein into the cytosolic regions, which stimulated DKC1 expression. We also identified Met338 in PDIA3 as the oxidatively modified residue and validated the effect of oxidative modification using an ectopic expression system, a clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 knock-in system, and a xenograft mouse model. We observed that oxidatively modified PDIA3 promoted DKC1-mediated malignancy and survival of HCC cells in vitro and in vivo. HCC tissues showed a positive association with ROS, cytoplasmic PDIA3, and nuclear DKC1 levels. HCC patients with high PDIA3 protein and DKC1 mRNA levels also displayed reduced recurrence-free survival rates. Cumulatively, the results showed that cytoplasmic PDIA3 activity could be essential in raising DKC1 expression in HCC progression and predicting poor prognoses in HCC patients. Conclusion: Our study indicates that the elevated ROS levels in HCC modulate cytoplasmic PDIA3 levels, resulting in HCC cell survival through DKC1 up-regulation.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Ko E, Kim JS, Ju S, et al. Oxidatively Modified Protein-Disulfide Isomerase-Associated 3 Promotes Dyskerin Pseudouridine Synthase 1-Mediated Malignancy and Survival of Hepatocellular Carcinoma Cells. Hepatology. 2018. PMID: 29672884. doi:10.1002/hep.30039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。